TRRI logo

Alzex Neuropharma Inc. Stock Price

OTCPK:TRRI Community·US$451.0 Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

TRRI Share Price Performance

US$0.0003
-0.14 (-99.79%)
US$0.0003
-0.14 (-99.79%)
Price US$0.0003

TRRI Community Narratives

There are no narratives available yet.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

Alzex Neuropharma Inc. Key Details

US$4.7m

Revenue

US$4.3m

Cost of Revenue

US$430.1k

Gross Profit

US$398.1k

Other Expenses

US$32.1k

Earnings

Last Reported Earnings
Dec 31, 2011
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About TRRI

Founded
1971
Employees
n/a
CEO
Robert Rosner
WebsiteView website
www.trinresinc.com

Alzex Neuropharma Inc., a development stage biopharmaceutical company, engages in developing therapeutics for the treatment of Alzheimer's Disease and other neurological diseases. The company was formerly known as Trinity Resources Inc. and changed its name to Alzex Neuropharma Inc. in December 2022. The company was incorporated in 1971 and is headquartered in Las Vegas, Nevada.

Recent TRRI News & Updates

No updates

Recent updates

No updates